AlphaStocks
3.4
Weak

COOPER COMPANIES, INC. (COO)

Health Care / Health Care Supplies

S&P 500

$61.09

Scores poorly across most models. Proceed with caution.

Weak

Score based on 5 of 5 models — high confidence

#951out of 1126 in Health Care

Is COOPER COMPANIES, INC. a Good Investment in 2026?

COOPER COMPANIES, INC. (COO) scores 3.4 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Piotroski model rates COOPER COMPANIES, INC. as Attractive (6/9). The Greenblatt Magic Formula model is the least favorable, rating it Neutral. COOPER COMPANIES, INC. currently trades above its estimated fair value of $42, suggesting limited upside at current prices. COOPER COMPANIES, INC. ranks #951 out of 1126 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E32.6ROE4.5Market Cap12B

Estimated Fair Value

$41.6847% above

Trading above estimated fair value. Eps growth of -4% may not justify the premium.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

6/9

Buffett

Neutral

Business quality & competitive moat

Graham

Neutral

47% above fair value

Lynch

Neutral

High PEG — growth premium · Slow Grower

Greenblatt

Neutral

Top half (rank 44%)

Frequently Asked Questions

Is COOPER COMPANIES, INC. (COO) a good investment?
Based on AlphaStocks' composite analysis, COOPER COMPANIES, INC. (COO) scores 3.4 out of 10, earning a Weak rating. This score is below average, suggesting caution. Trading above estimated fair value. Eps growth of -4% may not justify the premium.
What is COOPER COMPANIES, INC.'s Piotroski F-Score?
COOPER COMPANIES, INC.'s Piotroski F-Score status is Attractive. The raw score is 6/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is COO overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $42, COO appears overvalued. The stock currently trades 47% above its estimated fair value. Trading above estimated fair value. Eps growth of -4% may not justify the premium.
How does COO compare to other Health Care stocks?
COOPER COMPANIES, INC. ranks #951 out of 1126 stocks in the Health Care sector, placing it in the top 84% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about COO?
AlphaStocks evaluates COO using five proven investment models. Piotroski: Attractive; Buffett: Neutral; Graham: Neutral; Lynch: Neutral; Greenblatt Magic Formula: Neutral. These models are combined into a single composite score of 3.4/10.

Similar Stocks

PARRAZNFTI

Compare COO with

COO vs PARRCOO vs AZNCOO vs FTI

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer